Home » Topics » BioWorld Science

BioWorld Science
RSS

Clinical results with VIMRxyn in AIDS

Sep. 27, 1996

A novel mechanism for inhibiting HIV infection using fibronectin fragments

Sep. 27, 1996

Animal and human results presented on Aronex's lead anti-HIV integrase inhibitor

Sep. 27, 1996

Ciba characterizes another novel HIV protease inhibitor

Sep. 27, 1996

U.K. introduction for lamivudine

Sep. 27, 1996

Novel class of HIV protease inhibitors with improved activity

Sep. 27, 1996

Anti-HIV research continues at Boehringer Ingelheim

Sep. 27, 1996

Anti-HIV bicyclic phosphoramides from DuPont Merck

Sep. 27, 1996

New antiinfluenza virus agent reported by Gilead Sciences

Sep. 27, 1996

Topical Reticulose reported to be effective against HPV

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026